Gentler Chemo-Free treatment tested for tough blood cancer
NCT ID NCT06429098
Summary
This study is testing a new treatment combination for adults newly diagnosed with a specific genetic type of acute myeloid leukemia (AML). The goal is to see if a regimen based on the drug venetoclax, which avoids harsh traditional chemotherapy drugs called anthracyclines, can effectively put the cancer into remission. Researchers will measure how well the treatment works and monitor its safety in 40 participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ethical Committee of the First Affiliated Hospital of Soochow University
RECRUITINGSuzhou, Jiangsu, 215000, China
Contact Phone: •••-•••-••••
-
The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology
RECRUITINGSuzhou, Jiangsu, 215000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.